EC-Naprosyn is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Canton Laboratories. The primary component is Naproxen.
| Product ID | 69437-416_0aa005eb-b5a2-4f9b-9fa8-0c543a7752b3 |
| NDC | 69437-416 |
| Product Type | Human Prescription Drug |
| Proprietary Name | EC-Naprosyn |
| Generic Name | Naproxen |
| Dosage Form | Tablet, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-06-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020067 |
| Labeler Name | Canton Laboratories |
| Substance Name | NAPROXEN |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2016-06-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020067 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-06-01 |
| Ingredient | Strength |
|---|---|
| NAPROXEN | 500 mg/1 |
| SPL SET ID: | 8bff5df5-d856-4237-b6a8-ae445b454844 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| UPC Code | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0004-6415 | EC-Naprosyn | naproxen |
| 69437-415 | EC-Naprosyn | EC-Naprosyn |
| 69437-416 | EC-Naprosyn | EC-Naprosyn |
| 0363-9609 | BACK AND MUSCLE PAIN | NAPROXEN |
| 0121-0899 | Naprosyn | Naproxen |
| 0121-1798 | Naprosyn | Naproxen |
| 0121-2697 | Naprosyn | Naproxen |
| 0054-3630 | Naproxen | Naproxen |
| 0093-1005 | Naproxen | Naproxen |
| 0093-1006 | Naproxen | Naproxen |
| 0143-1346 | Naproxen | Naproxen |
| 0143-1347 | Naproxen | Naproxen |
| 0143-1348 | Naproxen | Naproxen |
| 0179-1978 | Naproxen | Naproxen |
| 0440-1852 | Naproxen | Naproxen |
| 0440-7852 | Naproxen | Naproxen |
| 0615-1504 | Naproxen | Naproxen |
| 0615-3562 | Naproxen | Naproxen |
| 0615-3563 | Naproxen | Naproxen |
| 0615-7709 | Naproxen | Naproxen |
| 0615-7892 | Naproxen | Naproxen |
| 0615-8094 | Naproxen | Naproxen |
| 10544-010 | Naproxen | Naproxen |
| 10544-016 | Naproxen | Naproxen |
| 10544-019 | Naproxen | Naproxen |
| 10544-044 | Naproxen | Naproxen |
| 10544-061 | Naproxen | Naproxen |
| 10544-111 | NAPROXEN | NAPROXEN |
| 10544-277 | Naproxen | Naproxen |
| 10544-278 | Naproxen | Naproxen |
| 10544-920 | Naproxen | Naproxen |
| 10544-922 | Naproxen | Naproxen |
| 10544-939 | Naproxen | Naproxen |
| 12634-498 | Naproxen | Naproxen |
| 12634-684 | Naproxen | Naproxen |
| 21695-084 | Naproxen | Naproxen |
| 21695-085 | Naproxen | Naproxen |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EC-NAPROSYN 74405354 1920671 Dead/Cancelled |
SYNTEX PUERTO RICO, INC. 1993-06-18 |
![]() EC-NAPROSYN 74401683 1920670 Live/Registered |
ATNAHS PHARMA US LIMITED 1993-06-14 |